Social Media Ideas for Pierre Fabre Laboratories

Laboratoires Pierre Fabre appoints Zombré CEO of U.S. Dermocosmetics operations in Secaucus

Laboratoires Pierre Fabre, the world’s second-largest dermo-cosmetics company and one of Europe’s leading pharmaceutical groups, announced Aug. 25 the appointment of Nicolas Zombré...

PhRMA names next CEO; Pierre Fabre takes third swing at Ebvallo approval

A former congressman will take over for prominent lobbyist Steve Ubl. Elsewhere, recent buyout deals paid dividends for Mirum and AbbVie.

Sanofi and Cheplapharm to create new strategic partnership in mature medicines

Sanofi and Cheplapharm, a European leader in well-established medicines, today announced their intention to create a strategic partnership under which Cheplapharm would take over f...

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Fayuvi]]>

Derm

Derm Anonymous (not verified) Wed, 10/07/2026 - 04:08 field_thread_url https://cafepharma.com/boards/threads/derm.690595/ board name...

PascualLab Banners 80th Anniversary with the Launch of Alevia-B and Mycolla C

One of the top pharmaceutical companies in the Philippines forays into the mobility market and  expands its beauty

<![CDATA[Pharmaceutical Executive Daily: Sanofi & Cheplapharm Form Strategic Partnership]]>

“DURABIO”, a bio-engineering plastic partly made from plant-derived isosorbide, is adopted for ALBION's cosmetic contain...

Mitsubishi Chemical Corporation (Head office: Chiyoda-ku, Tokyo; President and CEO: Manabu Chikumoto) is pleased to announce that the plant-derived bio-engineering plastic DURABIOв...

Piramal Pharma Solutions Launches New Microbiology Laboratory at Its Lexington, KY Sterile Injectable Facility

PRNewswireMumbai (Maharashtra) [India], October 6: Piramal Pharma Solutions ('PPS'), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal...

<![CDATA[Roundup: GSK Acquires Trispecific T Cell-Engager from Chimagen, Sanofi & Cheplapharm Form Strategic Part...

Odyssée

Odyssée is founded upon a philosophy of integrity in our approach to aesthetic medicine. This manifests in evidence-based treatments, a timeless approach rather than following tren...

<![CDATA[METiS Enters Collaboration with Eli Lilly for Next-Generation Tissue-Specific LNP Delivery Technologies]]&gt...

<![CDATA[M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to...

Viatris’s pipeline strategy: Moving beyond generics to find new growth 

Delve into the strategy of Viatris, a company that built its reputation around generics and is steadily moving beyond to find new growth. The post Viatris’s pipeline strategy: Movi...

<![CDATA[Roundup: Shionogi Inc. Acquires IntraBio, Gate Bioscience extends Collaboration with Eli Lilly, Alector Ente...

Pfizer Pill’s Phase 3 Data in Vitiligo Pave Way for FDA, EMA Submissions

Pfizer’s Litfulo significantly improved skin pigment measures in two pivotal studies in vitiligo, results that were presented during the European Academy of Dermatology and Venereo...

VERDOT Opens its New Centre of Excellence and Manufacturing Facility in Saint-Beauzire, France

VERDOT, a specialist in purification technologies for the biopharmaceutical industry, strengthens its production capacity with a new site designed to support more sustainable opera...

Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month

PRNewswireMumbai (Maharashtra) [India], October 1: Piramal Pharma Solutions ('PPS'), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal...

<![CDATA[Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Jemperli]]>

Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and Unite...

Pacira BioSciences today announced a strategic partnership with Molteni Farmaceutici to expand access to opioid-sparing postsurgical pain management across European markets.

<![CDATA[Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTe...

Aurobindo’s arm, Acrotech Biopharma, launches Adquey in US

The launch marks Acrotech’s entry into the US dermatology market and expands the company’s commercial presence into a new strategic therapeutic area

<![CDATA[Your Questions Answered: Two FDA Approvals, Six Platform Deals, and a European Warning]]>

<![CDATA[Roundup: Nanexa, Earendil Labs, and Atavistik Bio Enter Platform Deals with Novo Nordisk, Genentech, and Roc...